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Background: Intracranial hemorrhage in central nervous system lymphoma is extremely rare. T2*-weighted
gradient-echo magnetic resonance imaging is of particularly use in detecting silent hemorrhage as hypointense
signals due to the deposition of paramagnetic hemosiderin or mineralization. Multifocal hemosiderin depositions
caused by chronic silent hemorrhage have not yet been identified in patients with central nervous system involvement
of systemic lymphoma. We present an unexpected radiographic feature on T2*-weighted gradient-echo magnetic
resonance imaging in a patient with central nervous system involvement of pathologically confirmed systemic diffuse
large B-cell lymphoma.
Case presentation: A 56-year-old woman presented with lower extremities weakness and progressive cognitive
decline for four months. Conventional brain magnetic resonance imaging demonstrated multiple lesions with
hypointensities on T1-weighted images and hyperintensities on T2-weighted images and fluid attenuated inversion
recovery in both hemispheres. She was then transferred to our hospital.
Neurological examination showed impaired cognitive functions. Contrast-enhanced magnetic resonance imaging
revealed irregular spotty enhancement within the lesions. T2*-weighted gradient-echo magnetic resonance imaging
revealed diffuse hemosiderin depositions with hypointensities mostly adjacent to the cortex, which are not compatible
with the lesions visualized on T1-weighted images. Whole body positron emission tomography/computed tomography
scanning showed multiple hyper-metabolic foci in the pelvic cavity and the spleen. The pathological diagnosis of the
biopsy specimen was consistent with diffuse large B-cell lymphoma.
Conclusion: This is the first report of pathologically confirmed case of CNS involvement of systemic diffuse large B-cell
lymphoma with multifocal silent hemosiderin depositions detected by T2*-weighted gradient-echo magnetic
resonance imaging. Even though uncommon, our report offers an insight that CNS lymphoma could present with
multifocal silent hemosiderin depositions on T2*-weighted gradient-echo magnetic resonance imaging. Further studies
were expected for exploring the association between this radiologic feature and systemic lymphoma and their
underlying mechanisms.
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Systemic non-Hodgkin lymphoma (NHL) may present
variously in the central nervous system (CNS) involve-
ment, of which parenchymal infiltration and leptomenin-
geal metastases are the most common types. The
radiographic lesions tend to be non-hemorrhagic in the
majority of cases. Intracranial hemorrhage in CNS lymph-
oma is extremely rare, and it was only reported in three
case reports [1-3].
Hemorrhagic lesions in regular magnetic resonance
imaging (MRI) are usually variable according to different
clinical phases, while T2*-weighted gradient-echo mag-
netic resonance imaging (T2*-weighted MRI) is more
sensitive and of particular use in detecting silent hemor-
rhage (including cerebral microbleeds and superficial
siderosis etc.) as hypointense signals due to the deposition
of paramagnetic hemosiderin or mineralization (e.g. cal-
cium or iron) [4,5]. Herein, we present an unexpected
radiographic feature on T2*-weighted MRI in a patient
with CNS involvement of pathologically confirmed sys-
temic diffuse large B-cell lymphoma.
Case presentation
A 56-year-old woman presented with lower extremities
weakness and progressive cognitive decline for four
months. Initial laboratory studies revealed a mild anemia
(hemoglobin level of 90 g/L). Erythrocyte sedimentation
rate (44 mm/h) and serum C-reactive protein levels
(50.71 mg/L) as well as serum lactic dehydrogenase (867
U/L) were markedly elevated. The investigation of cere-
brospinal fluid (CSF) revealed no pleocytosis but a
slightly elevated protein concentration (0.97 g/L). Brain
MRI demonstrated multiple lesions with hypointensities
on T1-weighted images and hyperintensities on T2-
weighted images and fluid attenuated inversion recovery
(FLAIR) in the bilateral periventricular areas, centrum
semiovale and frontal lobes. She was then transferred to
our hospital for further management.
On admission, neurological examination showed cogni-
tive deficits in orientation, memory, calculation and lan-
guage with a Mini-Mental State Exam score of 8/30
points. The muscle force was graded as 4/normally 5 for
bilateral lower extremities with positive left Babinski sign.
While the serologic tests of treponemapallidum par-
ticle agglutination assay (TPPA) and fluorescent trepo-
nemal antibody absorption (FTA-ABS) IgG for syphilis
were positive, the same tests in CSF were nonreactive
plus the absence of relevant clinical manifestation, sug-
gesting the diagnosis of neuro-syphilis unwarranted. The
investigation of chemistry, cytology–particularly for neo-
plastic and atypical cells and other screening tests for
bacteria, fungi and viruses in CSF, were negative. The
serologic assay for human immunodeficiency virus was
negative.T1-weighted MRI demonstrated a hypointense area
with focal hyperintensity in the left temporal lobe, sug-
gesting newly patchy hemorrhage within the lesion. T2-
weighted MRI and FLAIR showed no changes compared
with the previous images (not shown). Part of lesions
showed irregular spotty enhancement after contrast, to-
gether with the enhancement of adjacent leptomeninges.
T2*-weighted MRI demonstrated multiple hypointensi-
ties in the right parietal lobe, bilateral basal ganglia and
cerebellum (Figure 1), indicating hemosiderin deposi-
tions, however, the locations were not compatible with
the hemorrhagic lesions visualized on T1-weighted im-
ages. Given the discrepancy between the lesions on T1-
weighted and T2*-weighted MRI, silent hemorrhage
caused by malignancy was suspected. The whole body
positron emission tomography/computed tomography
(PET/CT) scanning revealed multiple hypermetabolic
foci in pelvic cavity and the spleen, indicating malignant
lymphoma. Therefore, computed tomography-guided as-
piration biopsy of the retroperitoneal mass was per-
formed. Microscopic findings showed a diffuse growth
pattern of atypical lymphoid cells with CD20 positive on
immunohistochemistry, consistent with diffuse large B-
cell lymphoma. The patient declined chemo-radiotherapy,
and died of tumor progression four months later.
Discussion
Multifocal hemosiderin depositions caused by chronic
hemorrhage have not yet been identified in patients with
CNS involvement of systemic lymphoma [6]. Even in pri-
mary CNS lymphoma, hemorrhagic lesions are extremely
rare in immunocompetent patient [7]. Since 1990 to 2013,
only three cases of intracranial hemorrhage were reported
in primary CNS lymphoma. Rubenstein et al. [3] for the
first time reported intracranial hemorrhage in a patient
with primary CNS lymphoma. The intra-tumoral hemor-
rhage appeared hypointense on multiplanar gradient-
refocused image, due to magnetic susceptibility effect
caused by the blood-breakdown products. Kimura et al.
[1] described a patient with primary CNS lymphoma with
cortical laminar hemorrhage in the frontal cortex, showing
hypointensity in the cortex on T2*-weighted MRI. The bi-
opsy specimen revealed diffuse large B-cell lymphoma
with hemosiderin depositions. Different from these two
studies, in our case, the multifocal hypointensities indicat-
ing hemosiderin depositions detected by T2*-weighted
MRI located mostly adjacent to the cortex, which were
not compatible with the hemorrhagic lesions visualized on
T1-weighted MRI. To our knowledge, this is the first re-
port of pathologically confirmed case of secondary CNS
lymphoma with multifocal hemosiderin depositions on
T2*-weighted MRI. Importantly, physicians should be alert
to the diagnosis of systemic lymphoma when confronting
this unusual radiographic feature.
Figure 1 Axial brain magnetic resonance imaging including supratentorial and infratentorial regions after admission. (A) & (E) T1-weighted
imaging demonstrated a hypointense area with focal hyperintensity in the left temporal lobe (arrow), suggesting newly patchy hemorrhage within the
lesion. (B) & (F) T2-weighted imaging demonstrated multiple hyperintense lesions only involving the supratentorial region (arrows). (C) & (G) Fluid
attenuated inversion recovery (FLAIR) showed multiple hyperintense lesions only involving the supratentorial region (arrows). (D) & (H) T2*-weighted
MRI demonstrated diffuse hypointensities (arrowheads), indicating multifocal hemosiderin depositions in both supratentorial and infratentorial regions,
which were not compatible with the hemorrhagic lesions visualized on T1-weighted images.
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of CNS lymphoma, on which lymphoma usually appears
as non-hemorrhagic lesion. However, T2*-weighted MRI,
sensitive to cerebral hemorrhage, is not routinely em-
ployed. This may result in undetected silent hemorrhage
or microhemorrhage in some patients. In our case, T2*-
weighted MRI, played a very important role in providing
a valuable clue leading to the diagnosis of CNS lymph-
oma, taken together with the information on conven-
tional MRI. Even though uncommon, our report offers
an insight that CNS involvement of systemic diffuse
large B-cell lymphoma could present with multifocal si-
lent hemosiderin depositions on T2*-weighted MRI. The
conventional MRI including non-enhanced and contrast-
enhanced MRI is insufficient for detecting the lesions of
CNS lymphoma with diverse properties. T2*-weighted
MRI could be taken into account when confronted with
the patients suspected of having CNS lymphoma. We
expect further studies exploring the association between
this radiologic feature and systemic lymphoma and their
underlying mechanisms in order to better understand
and manage this life-threatening disease.
Cerebral amyloid angiopathy (CAA) is ranked highly
in the differential diagnosis of multifocal hemosiderin
depositions among elderly patients [8]. The most com-
mon clinical manifestation of spontaneous lobar hemor-
rhage and radiographic feature of restricted location in
lobar, cortical, or corticosubcortical regions were notdemonstrated in this case. Thus, the possible diagnosis
of CAA was less likely considered.
Conclusion
This is the first report of pathologically confirmed case
of CNS involvement of systemic diffuse large B-cell lym-
phoma with multifocal silent hemosiderin depositions
detected by T2*-weighted MRI. Even though uncom-
mon, our report offers an insight that CNS lymphoma
could present with multifocal silent hemosiderin deposi-
tions on T2*-weighted MRI. Further studies were expected
for exploring the association between this radiologic fea-
ture and systemic lymphoma and their underlying
mechanisms.
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